Javascript must be enabled to continue!
Large scale study of HPV genotypes in cervical cancer and different cytological cervical specimens in Thailand
View through CrossRef
AbstractIdentification of high‐risk HPV genotypes in patients is essential for vaccination and prevention programs while the geographic distribution of cervical cancer varies widely. HPV 16 is the major cause of cervical cancer followed by HPV 18, HPV 31, HPV 52, or HPV 58 depending on geographic area. In this study, the distribution of HPV genotypes in cervical specimens from women living in Thailand was analyzed by HPV testing with electrochemical DNA chip and PCR direct sequencing. The 716 specimens were grouped according to their cytological grades; 100 normal, 100 low‐grade squamous intraepithelial lesions, 100 high grade squamous intraepithelial lesions, and 416 specimens of cervical cancer. The results showed that HPV 16, HPV 18, HPV 52, and HPV 58 are the most common HPV genotypes in Thailand, respectively. With respect to age, women below the age of 26 years were almost negative for high‐risk HPV DNA exclusively. Conversely, high prevalence of high‐risk HPV DNA and abnormal cytology were usually found in women between 26 and 45 years while cervical cancer was detected mainly in women above the age of 45 years. To increase protection efficiency, a vaccine including HPV 52 and HPV 58 should be offered to Asian women, and primary HPV screening should start at 26–30 years of age. J. Med. Virol. 86:601–607, 2014. © 2013 Wiley Periodicals, Inc.
Title: Large scale study of HPV genotypes in cervical cancer and different cytological cervical specimens in Thailand
Description:
AbstractIdentification of high‐risk HPV genotypes in patients is essential for vaccination and prevention programs while the geographic distribution of cervical cancer varies widely.
HPV 16 is the major cause of cervical cancer followed by HPV 18, HPV 31, HPV 52, or HPV 58 depending on geographic area.
In this study, the distribution of HPV genotypes in cervical specimens from women living in Thailand was analyzed by HPV testing with electrochemical DNA chip and PCR direct sequencing.
The 716 specimens were grouped according to their cytological grades; 100 normal, 100 low‐grade squamous intraepithelial lesions, 100 high grade squamous intraepithelial lesions, and 416 specimens of cervical cancer.
The results showed that HPV 16, HPV 18, HPV 52, and HPV 58 are the most common HPV genotypes in Thailand, respectively.
With respect to age, women below the age of 26 years were almost negative for high‐risk HPV DNA exclusively.
Conversely, high prevalence of high‐risk HPV DNA and abnormal cytology were usually found in women between 26 and 45 years while cervical cancer was detected mainly in women above the age of 45 years.
To increase protection efficiency, a vaccine including HPV 52 and HPV 58 should be offered to Asian women, and primary HPV screening should start at 26–30 years of age.
J.
Med.
Virol.
86:601–607, 2014.
© 2013 Wiley Periodicals, Inc.
Related Results
High rate of non-vaccine-targeted high-risk HPV genotypes in Ethiopia: Its implication in future vaccine selection
High rate of non-vaccine-targeted high-risk HPV genotypes in Ethiopia: Its implication in future vaccine selection
Abstract
Since the distribution of high-risk HPV genotypes varies across countries, genotype-based vaccination is widely recommended to control the burden of cervical cance...
Knowledge and perception of HPV vaccination among Lebanese mothers of children between nine and 17-year-old
Knowledge and perception of HPV vaccination among Lebanese mothers of children between nine and 17-year-old
AbstractbackgroundHuman papillomavirus (HPV) is one of the most prevalent sexually transmitted viruses in the world, and is associated with many medical conditions cervical cancer ...
High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia
High rate of non-vaccine targeted high-risk HPV genotypes circulate among women in Eastern Ethiopia
Abstract
The World Health Organization [WHO] recommends a genotype-specific human papillomavirus [HPV] vaccination as a primary prevention st...
Prevalence and distribution of human papillomavirus genotypes in women with abnormal cervical cytology in Ethiopia: a systematic review and meta-analysis
Prevalence and distribution of human papillomavirus genotypes in women with abnormal cervical cytology in Ethiopia: a systematic review and meta-analysis
BackgroundCervical cancer is the 4th most common cancer in women globally. Determining the prevalence of the high-risk human papillomavirus (HR-HPV) and low-risk (LR-HPV) genotypes...
Cervical Cancer: What Vaccine in Senegal?
Cervical Cancer: What Vaccine in Senegal?
Introduction: Cervical cancer (CC) is first cancer in terms of frequency and mortality among women in Senegal. This is a public health problem hence the urgency of preventive measu...
Molecular epidemiology of human papillomavirus genotype in women with high‐grade squamous intraepithelial lesion and cervical cancer: Will a quadrivalent vaccine be necessary in Thailand?
Molecular epidemiology of human papillomavirus genotype in women with high‐grade squamous intraepithelial lesion and cervical cancer: Will a quadrivalent vaccine be necessary in Thailand?
AbstractThis study was designed to investigate the distribution of human papilomavirus (HPV) genotypes among a group of patients with high‐grade squamous intraepithelial lesion (HS...
Prevalence and Genotype Spectrum of HPV Infection among Women in Xuhui District, Shanghai: Insights for Regional Cervical Cancer Screening Strategies
Prevalence and Genotype Spectrum of HPV Infection among Women in Xuhui District, Shanghai: Insights for Regional Cervical Cancer Screening Strategies
Abstract
Objective: Numerous epidemiological analyses suggest that high-risk HPV infections are a major cause of cervical cancer, with variations in HPV distribution among ...
Abstract 2180: Immune, keratinocyte, and fibroblast expression signatures distinguish HNSCC samples by HPV status
Abstract 2180: Immune, keratinocyte, and fibroblast expression signatures distinguish HNSCC samples by HPV status
Abstract
Introduction
Head and neck squamous cell carcinoma (HNSCC) is the sixth leading cancer in the world. HPV-positive HNSCC is considered a disti...

